Connect with us

Published

on

WHO Confirms That Three West African Countries Introduce Malaria Vaccine—-The World Health Organisation (WHO) says the Republic of Benin, Liberia and Sierra Leone have launched a large-scale rollout of the life-saving malaria vaccine targeting millions of children across the three West African nations.

WHO said this in a statement as the world celebrates the  17th World Malaria Day  with theme: “Advancing health equity, gender equality and human rights,”.

The world health body said that the vaccine rollout, announced on World Malaria Day, seeks to further scale up vaccine deployment in the African region.

“Today’s launch brings to eight the number of countries on the continent to offer the malaria vaccine as part of the childhood immunisation programmes, extending access to more comprehensive malaria prevention.

“Several of the more than 30 countries in the African region that have expressed interest in the vaccine are scheduled to roll it out in the 2025 .

“This is through support from Gavi, the Vaccine Alliance, as efforts continue to widen its deployment in the region in coordination with other prevention measures such as long-lasting insecticidal nets and seasonal malaria chemoprevention,” it said.

According to it, Benin, which received 215,900 doses, has added the malaria vaccine to its Expanded Programme on Immunisation.

It said that the  malaria vaccine should be provided in a schedule of four doses in children from around five months of age.

“The introduction of the malaria vaccine in the Expanded Programme on Immunization for our children is a major step forward in the fight against this scourge.

Prof Benjamin Hounkpatin, Minister of Health,  Benin   reassure that the malaria vaccines are safe and effective and contribute to the protection of the children against the serious and fatal diseases.

Hounkpatin said that  in Liberia, the vaccine was launched in the southern Rivercess County and would be rolled out afterwards in five other counties which have high malaria burden.

” At least 45 000 children are expected to benefit from the 112 000 doses of the available vaccine,”  he said.

Also, Dr Louise Kpoto, Liberia’s Minister of Health said  for far too long, malaria has stolen the laughter and dreams of their children.

“But today, with this vaccine and the unwavering commitment of our communities, healthcare workers and our partners, including GAVI, UNICEF and WHO, we break the chain.

“We have a powerful tool that will protect them from this devastating illness and related deaths, ensuring their right to health and a brighter future.

“Let’s end malaria in Liberia and pave the way for a healthier, more just society,”  Kpoto said.

According to her , two safe and effective vaccines  RTS,S and R21  recommended by WHO , are  a breakthrough for child health and malaria control.

She said that a pilot malaria vaccine programme in Ghana, Kenya and Malawi reached over two million children from 2019 to 2023.

According to her ,such shows a significant reduction in malaria illness and a 13 per cent drop in overall child mortality and substantial reductions in hospitalisations.

Again, Dr Austin Demby, Minister of Health of Sierra Leone  said that in   Sierra Leone, the first doses were administered to children at a health centre in Western Area Rural where the authorities kicked off the rollout of 550 000 vaccine doses.

“The vaccine will then be delivered in health facilities nationwide.

“With the new, safe and efficacious malaria vaccine, we now have an additional tool to fight this disease. In combination with insecticide-treated nets, effective diagnosis and treatment, and indoor spraying, no child should die from malaria infection,”   Demby  said

According to him, malaria remains a huge health challenge in the African region, which is home to 11 countries that carry approximately 70 per cent of the global burden of malaria.

“The region accounted for 94% of global malaria cases and 95% of all malaria deaths in 2022, according to the World Malaria Report 2023,” he said.

Dr Matshidiso Moeti, WHO Regional Director for Africa said that African region was advancing in the rollout of the malaria vaccine ,  a game-changer in the fight against the deadly disease.

“Working with our member states and partners, we’re supporting the ongoing efforts to save the lives of young children and lower the malaria burden in the region,” she said.

Ms Aurelia Nguyen, Chief Programme Officer at Gavi, the Vaccine Alliance,  says “Today we celebrate more children gaining access to a new lifesaving tool to fight one of Africa’s deadliest diseases.

“This introduction of malaria vaccines into routine programmes in Benin, Liberia, and Sierra Leone alongside other proven interventions will help save lives and offer relief to families, communities and hard-pressed health systems,” she said.

Nguyen  said that progress against malaria has stalled in these high-burden African countries since 2017 due to factors including climate change, humanitarian crises, low access to and insufficient quality of health services, gender-related barriers, biological threats such as insecticide and drug resistance and global economic crises.

She said that other are fragile health systems and critical gaps in data and surveillance have compounded the challenge.

0Shares
Continue Reading
Click to comment

Leave a Reply

News

Virginia Representative Gerry Connolly Passes at 75 After Cancer Battle

Published

on

Gerry Connolly Passes at 75

Virginia Representative Gerry Connolly Passes at 75 After Cancer Battle—-Representative Gerry Connolly, a fiery Virginia Democrat with decades of experience on Capitol Hill, died Wednesday morning after a short stint with cancer, his family announced.

Connolly, 75, was a familiar figure around the halls of the Capitol, where he was known as a feisty advocate for the institutions of Washington — particularly following the Jan. 6, 2021, attack on the U.S. Capitol — and a champion of the many federal workers hailing from his Northern Virginia district.

First elected in 2008, Connolly rose this year to become the senior Democrat on the power House Oversight and Government Reform Committee — a seat he had sought unsuccessfully twice before.

His ascension was not without controversy. Connolly announced shortly after November’s elections that he was being treated for esophageal cancer, and a challenge for the ranking member seat from Rep. Alexandria Ocasio-Cortez (D-N.Y.) had rekindled the long-running generational debate over the role of seniority within the House Democratic Caucus.

Still, Connolly was a popular figure within the caucus, and he prevailed easily.

On Tuesday, Connolly joined forces with Rep. James Comer (R-Ky.), the chair of the Oversight Committee, to sponsor what would be his final piece of legislation: the Esophageal Cancer Awareness Act.

In a statement, Connolly’s family remembered him as a devoted family man and dedicated public servant, one who had served Northern Virginia for decades in both county and national politics.

“Gerry lived his life to give back to others and make our community better,” they wrote in a statement. “He looked out for the disadvantaged and voiceless. He always stood up for what is right and just.”

While pointing to Connolly’s accomplishments in elected office, the family said his greater contribution was to the local community, where he leaves behind a host of local projects that will serve as his legacy.

“[M]ore important than his accomplishments in elected office, Gerry lived by the ethos of ‘bloom where you are planted,’” they said. “From the Silver Line to the Oakton Library, Mosaic District to the Cross County Trail and beyond, his legacy now colors our region.”

Connolly’s illness had caused him to step back from his daily responsibilities on the Oversight Committee last month, when he tapped Rep. Stephen Lynch (D-Mass.), another senior member of the panel, to take the seat as interim ranking member — a temporary position requiring no elections.

With Connolly’s death, Democratic leaders will now start the process of seating a permanent replacement, which is likely to be fiercely contested and could pit senior members against a newer crop of up-and-coming Democrats clamoring to rise quickly in the ranks.

Lynch, 70, is among the most experienced Democrats on the panel, but several younger members — including Reps. Robert Garcia (D-Calif.) and Jasmine Crockett (D-Texas) — have expressed interest in the seat.

Ocasio-Cortez, for her part, has said she won’t seek the seat.

0Shares
Continue Reading

World

Former POTUS Joe Biden Diagnose With Advance Prostate Cancer

Published

on

Joe Biden Diagnose With Advance Prostate Cancer

Former POTUS Joe Biden Diagnose With Advance Prostate Cancer—-Former US President Joe Biden has been diagnosed with prostate cancer that has spread to his bones, a statement from his office said on Sunday.

Biden, 82, was diagnosed on Friday after he saw a doctor last week for urinary symptoms.

The cancer is a more aggressive form of the disease, characterised by a Gleason score of 9 out of 10. This means his illness is classified as “high-grade” and that the cancer cells could spread quickly, according to Cancer Research UK.

Biden and his family are said to be reviewing treatment options. The former president’s office added that the cancer is hormone-sensitive, meaning it can likely be managed.

After news broke of his diagnosis, the former president received support from both sides of the aisle.

President Donald Trump wrote on his social media platform Truth Social that he and First Lady Melania Trump “are saddened to hear about Joe Biden’s recent medical diagnosis.”

“We extend our warmest and best wishes to Jill and the family,” he said, referring to former First Lady Jill Biden. “We wish Joe a fast and successful recovery.”

Former Vice-President Kamala Harris, who served under Biden, wrote on X that she and her husband Doug Emhoff are keeping the Biden family in their prayers.

“Joe is a fighter — and I know he will face this challenge with the same strength, resilience, and optimism that have always defined his life and leadership,” Harris said.

The news comes nearly a year after the former president was forced to drop out of the 2024 US presidential election over concerns about his health and age. He is the oldest person to hold the office in US history.

Biden, then the Democratic nominee vying for re-election, faced mounting criticism of his poor performance in a June televised debate against Republican nominee and current president Donald Trump. He was replaced as the Democratic candidate by his vice president Harris.

Prostate cancer is the second most common cancer affecting men, behind skin cancer, according to the Cleveland Clinic. The US Centres for Disease Control and Prevention (CDC) says that 13 out of every 100 men will develop prostate cancer at some point in their lives.

Age is the most common risk factor, the CDC says.

Dr William Dahut, the Chief Scientific Officer at the American Cancer Society and a trained prostate cancer physician, told the BBC that the cancer is more aggressive in nature, based on the publicly-available information on Biden’s diagnosis.

“In general, if cancer has spread to the bones, we don’t think it is considered a curable cancer,” Dr Dahut said.

He noted, however, that most patients tend to respond well to initial treatment, “and people can live many years with the diagnosis”.

Dr Dahut said that someone with the former president’s diagnosis will likely be offered hormonal therapies to mitigate symptoms and to slow the growth of cancerous cells.

Biden had largely retreated from the public eye since leaving the White House and he has made few public appearances.

The former president delivered a keynote speech in April at a Chicago conference held by the Advocates, Counselors, and Representatives for the Disabled, a US-based advocacy group for people with disabilities.

In May, he sat down for an interview with the BBC – his first since leaving the White House – where he admitted that the decision to step down from the 2024 race was “difficult”.

Biden has faced questions about the status of his health in recent months.

In an appearance on The View programme that also took place in May, Biden denied claims that he had been experiencing cognitive decline in his final year at the White House. “There is nothing to sustain that,” he said.

For many years, the president had advocated for cancer research. In 2022, he and Mrs Biden relaunched the Cancer Moonshot initiative with the goal of mobilising research efforts to prevent more than four million cancer deaths by the year 2047.

Biden himself lost his eldest son, Beau, to brain cancer in 2015.

0Shares
Continue Reading

Trending

0Shares